DK1164996T3 - Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner - Google Patents

Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner

Info

Publication number
DK1164996T3
DK1164996T3 DK00916981T DK00916981T DK1164996T3 DK 1164996 T3 DK1164996 T3 DK 1164996T3 DK 00916981 T DK00916981 T DK 00916981T DK 00916981 T DK00916981 T DK 00916981T DK 1164996 T3 DK1164996 T3 DK 1164996T3
Authority
DK
Denmark
Prior art keywords
nicotine
added
therapeutic system
transdermal therapeutic
monoterpenic
Prior art date
Application number
DK00916981T
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1164996T3 publication Critical patent/DK1164996T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00916981T 1999-03-26 2000-03-21 Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner DK1164996T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19913732A DE19913732A1 (de) 1999-03-26 1999-03-26 Nikotin-TTS mit einem Zusatz von Monoterpenketonen
PCT/EP2000/002457 WO2000057824A1 (de) 1999-03-26 2000-03-21 Nikotin-tts mit einem zusatz von monoterpenketonen

Publications (1)

Publication Number Publication Date
DK1164996T3 true DK1164996T3 (da) 2004-02-16

Family

ID=7902491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00916981T DK1164996T3 (da) 1999-03-26 2000-03-21 Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner

Country Status (23)

Country Link
US (1) US7029692B1 (da)
EP (1) EP1164996B1 (da)
JP (1) JP4750282B2 (da)
KR (1) KR100597802B1 (da)
CN (1) CN1199623C (da)
AR (1) AR027485A1 (da)
AT (1) ATE252356T1 (da)
AU (1) AU769656B2 (da)
BR (1) BR0010515A (da)
CA (1) CA2367615C (da)
CZ (1) CZ300409B6 (da)
DE (2) DE19913732A1 (da)
DK (1) DK1164996T3 (da)
ES (1) ES2211523T3 (da)
HU (1) HUP0200189A3 (da)
IL (1) IL145502A0 (da)
NZ (1) NZ514423A (da)
PT (1) PT1164996E (da)
RU (1) RU2228740C2 (da)
TR (1) TR200102605T2 (da)
TW (1) TWI227666B (da)
WO (1) WO2000057824A1 (da)
ZA (1) ZA200107864B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002011768A1 (en) * 2000-08-03 2002-02-14 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR100699582B1 (ko) 2005-07-11 2007-03-23 삼성전기주식회사 출력 버퍼회로
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
EP1774964B1 (en) 2005-10-13 2014-08-06 Nitto Denko Corporation Nicotine transdermal preparation and production method thereof
NZ571460A (en) * 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
CN101264277B (zh) * 2008-04-16 2012-09-26 冯冲 一种控烟戒烟复方精油
RU2573293C2 (ru) * 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов
JP5730355B2 (ja) * 2013-07-24 2015-06-10 学校法人近畿大学 Ｃｙｐ２ａ１３阻害剤
JP6888974B2 (ja) * 2016-01-27 2021-06-18 学校法人近畿大学 Ｃｙｐ２ａ１３阻害活性を有する化合物及びｃｙｐ２ａ１３阻害剤
US20190083386A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3559655A (en) * 1969-02-25 1971-02-02 Sutton Res Corp Oxidized cellulose substitute smoking material and method of making same
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH01157921A (ja) * 1987-12-15 1989-06-21 Tsumura & Co 二重盲検試験用製剤の製造方法
JPH01290608A (ja) * 1988-05-18 1989-11-22 Sunstar Inc 殺菌剤組成物
ES2062093T3 (es) * 1988-08-02 1994-12-16 Ciba Geigy Ag Emplasto de varias capas.
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
JPH0748190B2 (ja) * 1990-01-22 1995-05-24 株式会社東芝 キャッシュメモリ内蔵マイクロプロセッサ
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
JPH06181972A (ja) * 1992-12-18 1994-07-05 Kanebo Ltd 煙草臭消臭剤
US5520924A (en) * 1993-07-09 1996-05-28 Mizu Systems Corporation Methods and articles for administering drug to the oral cavity
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
JPH07133490A (ja) * 1993-11-10 1995-05-23 Pola Chem Ind Inc 消臭剤
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
JPH09110680A (ja) * 1995-10-19 1997-04-28 Yuutoku Yakuhin Kogyo Kk 皮膚炎治療貼付剤
JPH10130118A (ja) * 1996-10-25 1998-05-19 Lion Corp 外用剤組成物
JPH10306030A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd 外用剤組成物

Also Published As

Publication number Publication date
DE50004156D1 (de) 2003-11-27
AU3813400A (en) 2000-10-16
US7029692B1 (en) 2006-04-18
JP4750282B2 (ja) 2011-08-17
EP1164996A1 (de) 2002-01-02
ATE252356T1 (de) 2003-11-15
PT1164996E (pt) 2004-03-31
HUP0200189A3 (en) 2011-02-28
TR200102605T2 (tr) 2002-01-21
AU769656B2 (en) 2004-01-29
CN1199623C (zh) 2005-05-04
HUP0200189A2 (hu) 2002-05-29
IL145502A0 (en) 2002-06-30
KR100597802B1 (ko) 2006-07-10
CA2367615A1 (en) 2000-10-05
CA2367615C (en) 2009-10-13
RU2228740C2 (ru) 2004-05-20
BR0010515A (pt) 2003-07-22
WO2000057824A1 (de) 2000-10-05
CZ20013457A3 (cs) 2002-03-13
EP1164996B1 (de) 2003-10-22
DE19913732A1 (de) 2000-09-28
TWI227666B (en) 2005-02-11
ES2211523T3 (es) 2004-07-16
NZ514423A (en) 2003-08-29
KR20010112366A (ko) 2001-12-20
CN1345213A (zh) 2002-04-17
ZA200107864B (en) 2002-11-27
CZ300409B6 (cs) 2009-05-13
AR027485A1 (es) 2003-04-02
PL351313A1 (en) 2003-04-07
JP2002540125A (ja) 2002-11-26

Similar Documents

Publication Publication Date Title
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DK1164996T3 (da) Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO20022656D0 (no) Caspaseinhibitorer og anvendelse derav
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20015362D0 (no) Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
DK1233763T3 (da) Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20020569D0 (no) Substituerte pyridaziner og kondenserte pyridaziner med angiogenese - inhiberende virkning
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO20023028L (no) Substituerte pyrrol-mannich baser for bekjemping av smerter og allergiske reaksjoner
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
NO995966D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
DK1177196T3 (da) Heteroaryldiazabicycloalkaner, deres fremstilling og anvendelse